GILD 241213 93.00C (GILD241213C93000) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

GILD241213C93000

Watchlist

0.13
-0.30-69.77%

15min DelayClose Dec 12 16:00 ET

0.47High0.13Low

Intraday

5D
Daily

News

Gilead Sciences: Berger to Succeed Merdad Parsey on Jan. 2
Dow Jones36minutes ago
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer
Businesswire37minutes ago
Express News | Gilead Sciences Appoints Dietmar Berger, Md, Phd, as Chief Medical Officer
Reuters37minutes ago
Gilead Sciences Options Spot-On: On December 12th, 87,424 Contracts Were Traded, With 259.6K Open Interest
Moomoo News16:30 ET
Thursday Ends in Index Declines | Wall Street Today
Kevin Travers16:29 ET
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Benzinga13:13 ET

Comments

$Gilead Sciences (GILD.US)$
low attention stock, just another day!

Share Your Profit/Loss

6

$Gilead Sciences (GILD.US)$ $Merck & Co (MRK.US)$

1

$Gilead Sciences (GILD.US)$

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Read more